Ranked against its own peers
Stocks, funds, commodities and crypto, each weighed against its own kind, with the case for and against side by side.
Research · Risk · Record · AI
ThesisLens brings investment research, portfolio risk, every client book a firm runs, and an AI that challenges the case into one place, built so every number can be checked.
Research synthesis, not a recommendation.
The platform
Research says what an asset is. Risk says what it does to the whole book. The record keeps why it was chosen. IRIS argues with all three.
Stocks, funds, commodities and crypto, each weighed against its own kind, with the case for and against side by side.
Concentration, sectors, how holdings move together, what the funds really hold, and how many days each position would take to sell.
Every decision with its reason, who approved it and what followed. A correction is a new record; nothing is overwritten.
IRIS writes the case where none exists, argues the other side, and drafts the words, and you keep or remove every sentence.
For advisory firms · ThesisLens Charter
Clients follow a model portfolio. One decision on the model reaches every client who follows it, each one recorded on that client's own page.
ANALYSTDraft the reason for this decision from my notes.
IRIS · DRAFTThe position is reduced to bring the client back within the model's sector limit. kepttied to a recorda sentence it could not tie
Illustration. Nothing is saved until the analyst keeps it.
IRIS, our AI
IRIS works on words, never on decisions: it never picks a name, a weight or a size.
Principles
How it behaves when the evidence is thin, or when it fails.
What did not hold up is shown and marked, never quietly dropped.
A missing input leaves the figure absent, and says why.
Each changed rating is written into a dated record every morning.
ThesisLens does not trade or hold money.
Two editions
ThesisLens Navigator for an investor's own research. ThesisLens Charter for an advisory firm, its clients and its records.
ThesisLens is in active development. This site introduces it; it does not offer a public subscription or accept payments.
No. It is a research and decision-support product. It does not execute trades or hold client funds, and users remain responsible for their decisions.
Prices, filings and public lists from named vendors and regulators, each traced to its source.
Clarity through evidence
info@thesislens.app